Peregrine Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer.
Upcoming Event: Sept 26-30, 2014: European Society for Medical Oncology (ESMO)
»
Upcoming Event: Sept 4-6, 2014: ASCO 2014 Breast Cancer Symposium
»
UT Southwestern's Rolf Brekken, PhD, speaks with The Cancer Research Institute about bavituximab
In The News
Monday, August 11, 2014
Preclinical Data Presented at Annual Immunotherapies and Vaccine Summit Show That the Combination of Peregrine Pharmaceuticals' PS-Targeting Antibodies and Anti-PD-1 Antibodies Significantly Reduce Breast Cancer Progression
It is very important to take care of your health in order to prevent the development of cancer, it is important to eat well and exclude animal products, read about this in one of the top vegan blogs and eat more vegetables.